ERT Expands Corporate Presence in Japan  

ERT, a global technology-driven provider of health outcomes research services has announced significant milestones that reinforce its position as a leading eClinical trial solutions provider in Japan.

The Company has completed registration for Kabushiki Kaisha (KK) in Japan and has formed a fully-owned subsidiary, ERT Asia Group, Ltd enabling it to broaden the local services it provides in Japan and establish a solid foundation to expand its Asian presence. Along with this registration, ERT will grow the number of local resources that will work directly with its customers to deploy Japan-based projects.

“We are pleased to have collaborated with so many global and domestic biopharmaceutical organizations on their Japanese-based clinical trials and to have delivered the valuable data they need to evaluate their products’ safety and efficacy profiles,” said Robert Brown, Vice President, Business Development Asia-Pacific at ERT.

“Increasing the number of local ERT resources will enable us to work more collaboratively with our customers and our excellent partners in Japan and other Asian countries to increase efficiencies in study execution and improve the integrity of data collected in clinical research.”